Authors of the article "Hypermetabolism in 18F-FDG PET Predicts Favorable Outcome Following Decompressive Surgery in Patients with Degenerative Cervical Myelopathy"include Frank W. Floeth and Jörg Herdmann, Department of Neurosurgery, University Düsseldorf, Düsseldorf, Germany, and Department of Spine and Pain, St. Vinzenz Hospital, Düsseldorf, Germany; Norbert Galldiks, Institute of Neuroscience and Medicine, Research Center Jülich, Jülich, Germany, and Department of Neurology, University of Cologne, Cologne, Germany; Sven Eicker and Hans-Jakob Steiger, Department of Neurosurgery, University Düsseldorf, Düsseldorf, Germany; Gabriele Stoffels and Karl-Josef Langen, Institute of Neuroscience and Medicine, Research Center Jülich, Jülich, Germany; Gerald Antoch, Department of Diagnostic and Interventional Radiology, University Düsseldorf, Düsseldorf, Germany; and Sasha Rhee, Department of Spine and Pain, St. Vinzenz Hospital, Düsseldorf, Germany.
Please visit the SNMMI Newsroom to view the PDF of the study, including images, and more information about molecular imaging and personalized medicine. To schedule an interview with the researchers, please contact Susan Martonik at (703) 652-6773 or smartonik@snmmi.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI's more than 19,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
Media Contact:
Susan Martonik
(703) 652-6773
smartonik@snmmi.org
Back to HCB News
